/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ABCL — AbCellera Biologics Inc. Common Shares

Nasdaq

AbCellera Biologics Inc. Common Shares

Back to Screener
$13.91
-0.68(-4.66%)
O
14.59
H
14.65
L
13.79
V
7.76M
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

AbCellera Biologics Inc. Common Shares Statistics

Total Valuation

Market Cap$4.12B
Enterprise Value$4.05B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding306.61M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio44.87
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-93.87
EV / Salesn/a
EV / EBITDA-91.00
EV / EBIT-76.19
EV / FCF-108.47

Financial Position

Current Ratio1.41
Quick Ration/a
Debt / Equity0.14
Debt / EBITDA-0.30
Debt / FCF-0.36
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-46.01%
Return on Assets (ROA)-33.02%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-76,806
Employee Count562
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax-$6.37M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+133.39%
50-Day Moving Average$10.37
200-Day Moving Average$5.93
Relative Strength Index (RSI)76.31
Average Volume (20 Days)4,814,943

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-$53.18M
Pretax Income-$49.54M
Net Income-$43.16M
EBITDA-$44.52M
EBIT-$53.18M
Loss Per Share$-0.14

Balance Sheet

Cash & Cash Equivalents$77.06M
Total Debt$13.43M
Net Cash$63.63M
Net Cash Per Share$0.21
Equity (Book Value)$93.81M
Book Value Per Share$0.31
Working Capital$19.17M

Cash Flow

Operating Cash Flow-$28.55M
Capital Expenditures-$3.83M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$37.35M
FCF Per Share$-0.12

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-0.91%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a